Jin Medical International Ltd. ZJYL

What this company does

We operate our wheelchair and living aids product design and manufacture business through Changzhou Zhongjin and its wholly owned subsidiaries, Zhongjin Taizhou and Zhongjin Jing’ao Trading, in China. On March 30, 2023, the Company closed its initial public offering (“IPO”) of 1,000,000 Ordinary Shares, pursuant to its registration statement on Form F-1 (File No.333-259767), which was declared effective by the SEC on March 27, 2023. We control Changzhou Zhongjin through a series of contractual arrangements, or “VIE Agreements”, which are described under “Contractual Arrangements among WFOE, Changzhou Zhongjin and Changzhou Zhongjin’s Shareholders.” Our business focuses primarily on wheelchairs. Our employees are not covered by any collective bargaining agreement.

Written from the business description in Jin Medical International Ltd.'s annual report to the U.S. Securities and Exchange Commission, filed 10 February 2026. Every sentence was checked against that document before publication.